DexCom, Inc.

DXCM ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $1.11B $1.12B $917.7M $1.84B $1.16B $904.9M $606.1M $621.2M
Accounts Receivable $1.26B $1.09B $1.22B $1.11B $1.35B $1.16B $1.01B $1.00B
Inventory $726.4M $693.6M $629.1M $604.1M $570.7M $538.2M $542.6M $586.3M
Total Current Assets $4.09B $4.33B $4.03B $5.22B $5.03B $4.55B $4.30B $4.26B
Property, Plant & Equipment — — — — — — — —
Goodwill $24.1M $24.2M $24.2M $24.1M $24.1M $23.1M $22.8M $23.8M
Intangible Assets (Excl. Goodwill) $101.6M $62.6M $70.8M $79.0M $87.2M $95.2M $103.4M $106.2M
Total Assets $6.46B $6.63B $6.34B $7.50B $7.33B $6.75B $6.48B $6.35B
Liabilities
Accounts Payable $423.8M $394.3M $344.3M $451.5M $472.0M $432.0M $345.3M $326.6M
Total Current Liabilities $2.36B $2.22B $2.14B $3.34B $3.31B $3.04B $2.93B $1.73B
Long-Term Debt — — — — — — — —
Total Liabilities $3.83B $3.68B $3.59B $4.77B $4.75B $4.49B $4.38B $4.37B
Stockholders' Equity
Retained Earnings $2.88B $2.63B $2.43B $2.17B $1.88B $1.70B $1.60B $1.45B
Total Stockholders' Equity $2.62B $2.96B $2.75B $2.73B $2.57B $2.27B $2.10B $1.98B
← Newer Page 1 of 8 Older →